Clinical Trials Logo

Filter by:
NCT ID: NCT03533504 Enrolling by invitation - Hemophilia A Clinical Trials

Web Accessible Population Pharmacokinetics Service - Hemophilia: Sources of Variability

WAPPS-Hemo
Start date: May 9, 2018
Phase:
Study type: Observational

Using anonymized patient data collected as part of the WAPPS-Hemo project to explore the sources of variability in individual pharmacokinetics (PK); use the sources of variability to improve the performance of the WAPPS-Hemo models through the addition of the predictors of PK variability as covariates.

NCT ID: NCT03533452 Completed - Clinical trials for Anesthesia; Functional

The Impact of a Preoperative Nerve Block on the Consumption of Sevoflurane

Start date: May 1, 2019
Phase: Phase 2/Phase 3
Study type: Interventional

Arthroscopic rotator cuff surgery of the shoulder is performed under general anesthesia. Pain control for after the surgery can be achieved purely with intravenous and oral pain medication or in combination with freezing of the nerves. Nerve freezing (nerve block) placed before surgery has the potential to substantially reduce the amount of inhaled anesthetic given to the patient during surgery. This can benefit the patient by minimizing the opioid usage after surgery and also reduce cost to the system in terms of duration of hospital stay. The purpose of the study is to investigate whether the inclusion of a nerve block to the general anesthetic for rotator cuff repair surgery will also reduce the amount of inhaled anesthetic and thereby lowering the environmental footprint from the anesthetic. The investigators of the proposed study plan to quantify the amount of inhaled anesthetic used for each case and will compare how the consumption is affected by whether the nerve block is applied before or after surgery. Patients will have a nerve block catheter (interscalene catheter) placed under ultrasound-guidance prior to the induction of general anesthetic by an experienced regional anesthesiologist. The nerve block catheter will be bolused with a solution to which the anesthesiologist is blinded which will either be local anesthetic or normal saline (sham). The general anesthetic will be conducted according to a the protocol with the aim of maintaining a standard anesthetic depth monitored by patient state index (PSI). Measurements of the MAC-Value (minimum alveolar concentration) of inhaled anesthetic will be recorded every five minutes and the total amount of volatile anesthetic (in ml and ml/kg) will be noted down by a blinded observer. At the end of the case the anesthesiologist blinded to the solution will inject another solution (now a saline (sham) or local anesthetic before the patient is woken up.

NCT ID: NCT03532542 Terminated - Clinical trials for Duchenne Muscular Dystrophy

An Extension Study to Evaluate Casimersen or Golodirsen in Patients With Duchenne Muscular Dystrophy

Start date: August 2, 2018
Phase: Phase 3
Study type: Interventional

The main objective of this study is to evaluate the safety and tolerability of long-term treatment with casimersen or golodirsen in patients with Duchenne muscular dystrophy (DMD).

NCT ID: NCT03532425 Terminated - HIV-1-infection Clinical Trials

B/F/TAF vs Atripla Double-Blind Switch Study in HIV-1 Infected Adults

Start date: October 29, 2018
Phase: Phase 4
Study type: Interventional

Atripla (ATP: FTC/TDF/EFV) was the first single pill treatment for HIV and was the most prescribed first-line treatment from approximately 2008 to 2013 for people infected with HIV. However, ATP has not been recommended as a "preferred" treatment for HIV since 2015, due to there now being single pill treatments that work better. There are a lot of people who are still taking ATP and it is working for them. However, it has the potential to cause serious side effects (chronic kidney disease and fractures and serious neurological effects). These side effects are caused by components in ATP (namely the TDF and EFV parts). Also, the efavirenz (EFV) component is not compatible for treatment of Hepatitis C (HCV) - which is often also seen in people who have HIV. For these reasons, there is a need to find a better alternative treatment for these people currently being treated with ATP.

NCT ID: NCT03532360 Active, not recruiting - Peanut Allergy Clinical Trials

Peanut and Tree Nut Desensitization

Start date: February 19, 2018
Phase: N/A
Study type: Interventional

this study evaluates whether tolerance to peanuts and tree nuts can be induced in patients through a process of oral immunotherapy. Participants will be randomized into groups receiving oral immunotherapy and a control group that will receive no intervention

NCT ID: NCT03532113 Completed - Clinical trials for Inhibition (Psychology)

Attentional Control Training in Older Adults: Efficacy, Transfer and Brain Substrates

Start date: October 19, 2017
Phase: N/A
Study type: Interventional

Formal education and cognitively stimulating hobbies and profession have a protective effect against age-related cognitive decline and Alzheimer's disease. It is therefore possible that providing cognitively stimulating interventions at a later age increases neuroplasticity and brain resilience. Processes of updating and inhibition are both impaired by aging. Several studies have shown that updating can be improved but very few studies targeted inhibition in spite of the fact that it is impaired in older adults. The aim of this study is to assess the effect of cognitive interventions that will target either of these two components. The investigators will examine the effect on behavior, brain measures and transfer tasks. The investigators will also assess whether the efficacy varies as a function of personal variables such as prior cognitive profile, reserve proxies, genetic polymorphisms and brain markers.

NCT ID: NCT03532009 Terminated - Heart Failure Clinical Trials

Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy With Sodium Zirconium Cyclosilicate in Heart Failure

PRIORITIZE HF
Start date: June 26, 2018
Phase: Phase 2
Study type: Interventional

This is an international, multicentre, parallel-group, randomised, double-blind, placebo controlled, phase II study to evaluate the benefits and risks of using sodium zirconium cyclosilicate (ZS) to initiate and intensify renin angiotensin aldosterone system inhibitor (RAASi) therapy in heart failure patients.

NCT ID: NCT03531957 Completed - Atopic Dermatitis Clinical Trials

Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)

Start date: July 5, 2018
Phase: Phase 2
Study type: Interventional

This is a randomized double-blind/placebo study evaluate the efficacy of ASN002 in subjects with moderate to severe atopic dermatitis (AD).

NCT ID: NCT03531697 Completed - Clinical trials for Inflammation Following Ocular Surgery

Study of Loteprednol Etabonate in Adults Undergoing Bilateral Cataract Surgery

Start date: April 26, 2018
Phase: Phase 1
Study type: Interventional

This study will assess the bioequivalence of Loteprednol Etabonate and the reference listed drug (RLD)

NCT ID: NCT03531476 Not yet recruiting - Quality of Life Clinical Trials

Evaluation of a Pilot Shard-care Program for Patients With Chronic Pain in the Champlain-LHIN

Shared-Care
Start date: September 2022
Phase: N/A
Study type: Interventional

The study is evaluating an intervention consisting of a five week online mindfulness program for patients being referred to the Pain Clinic and triaged to eConsult. A pain specialist will be in contact with the patient's family physician to confirm it's appropriate and then a therapist will initiate contact with the patient to assess eligibility. The therapist will be a registered health professional with experience with patients with chronic health problems and will be supporting the online program where the participant will have communication access to them. Questionnaires will be sent at three time points to assess changes.